ClinicalTrials.Veeva

Menu

Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study

T

Technical University of Munich

Status

Unknown

Conditions

Adenoma

Treatments

Device: EMR
Device: over- the- scope full- thickness resection device (FTRD)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Adenomatous lesions of the colon are premalignant lesions which have the potential to develop cancer. Therefore adenomas should be resected endoscopically (endo- mucosa resection, EMR). EMR is conducted after submucosal injection of saline which allows to lift the desired lesion prior to resection. In some cases EMR is complicated due to incomplete or failed lifting after the injection of saline. This so- called "non- lifting" sign is a predictor for malignancy of the lesion. Difficult- to- lift polyps are also difficult- to- resect. A higher proportion of these lesions fail to be resected completely using the EMR technique.

Alternatively, an over- the- scope full- thickness resection device (FTRD) can be used in order to resect colonic lesions. The FTRD technique has been described elsewhere (Schmidt et al. Gastroenterology 2014; 147: 740-742.e2). No comparative data exists until now on the performance of FTRD resection compared to standard EMR resection of difficult- to- resect colon adenomas.

In this study the investigators aim to compare the success of FTRD versus EMR of difficult- to- resect adenomatous lesions (≤ 20 mm).

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients ≥ 18 years
  • adenomatous lesion 10-20 mm in size with expected difficulties regarding EMR (e.g. "non- lifting sign")

Exclusion criteria

  • patients < 18 years
  • lesions > 20 mm in size
  • high risk carcinomas ("deep submucosal carcinoma")
  • American Society of Anesthesiologists (ASA) class IV and higher

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

EMR
Other group
Description:
Standard EMR technique
Treatment:
Device: EMR
FTRD
Experimental group
Treatment:
Device: over- the- scope full- thickness resection device (FTRD)

Trial contacts and locations

1

Loading...

Central trial contact

Peter Klare, MD; Stefan von Delius, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems